12/22/2014 – Salix Pharmaceuticals Ltd.
Issued: 12/22/2014
Salix Pharmaceuticals Ltd., SLXP:
1. In our Thurs., Dec. 18 Williams edge stocks meeting it was noted that Salix Pharmaceuticals was in a ‘Buy’ position at its current price of $115.00 for an immediate advance to $121.00, then $124.00 profit target (or higher).
2. Thurs. Dec. 18 session completed the advance from $115.00 to the $121.00 upside profit target (Thurs. session high, $121.51) prompting initial long position exit.
3. Our remaining long position was stopped out today at $114.30, resulting in a successful trade. Will message any further entry or indication in Salix Pharmaceuticals Ltd.
David Williams
Issued: 12/19/2014
Salix Pharmaceuticals, SLXP:
1. In yesterday’s (Thurs., Dec. 18) Williams edge stocks meeting it was noted that Salix Pharmaceuticals was in a ‘Buy’ position at its current price of $115.00 for an immediate advance to $121.00, then $124.00 profit target (or higher).
2. Yesterday’s session completed the advance from $115.00 to the $121.00 upside profit target (yesterday’s session high, $121.51) prompting initial long position exit.
3. A protective sell stop should now be placed at $114.30. This stop will be moved higher as the market continues to confirm. Will update.
David Williams
CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.